Anavex Life Sciences (AVXL) Cash from Operations Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | -7.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.27% |
| Sep 30, 2025 | -28.62% |
| Jun 30, 2025 | -20.90% |
| Mar 31, 2025 | 15.31% |
| Dec 31, 2024 | -51.28% |
| Sep 30, 2024 | 4.63% |
| Jun 30, 2024 | 11.69% |
| Mar 31, 2024 | -16.79% |
| Dec 31, 2023 | 2.40% |
| Sep 30, 2023 | 2.21% |
| Jun 30, 2023 | -23.69% |
| Mar 31, 2023 | -17.28% |
| Dec 31, 2022 | -0.40% |
| Sep 30, 2022 | -16.86% |
| Jun 30, 2022 | 2.03% |
| Mar 31, 2022 | -30.56% |
| Dec 31, 2021 | 5.59% |
| Sep 30, 2021 | -23.72% |
| Jun 30, 2021 | -53.29% |
| Mar 31, 2021 | -37.40% |
| Dec 31, 2020 | -29.55% |
| Sep 30, 2020 | -41.84% |
| Jun 30, 2020 | -10.79% |
| Mar 31, 2020 | -96.11% |
| Dec 31, 2019 | -21.99% |
| Sep 30, 2019 | -10.80% |
| Jun 30, 2019 | -49.97% |
| Mar 31, 2019 | -31.55% |
| Dec 31, 2018 | -8.61% |
| Sep 30, 2018 | -41.41% |
| Jun 30, 2018 | -13.44% |
| Mar 31, 2018 | -61.45% |
| Dec 31, 2017 | -73.51% |
| Sep 30, 2017 | -33.71% |
| Jun 30, 2017 | -45.78% |
| Mar 31, 2017 | -26.15% |
| Dec 31, 2016 | -93.54% |
| Sep 30, 2016 | -56.67% |
| Jun 30, 2016 | -310.32% |
| Mar 31, 2016 | -145.04% |
| Dec 31, 2015 | -191.15% |
| Sep 30, 2015 | -78.52% |
| Jun 30, 2015 | -81.63% |
| Mar 31, 2015 | -80.39% |
| Dec 31, 2014 | 13.96% |
| Sep 30, 2014 | 0.21% |
| Jun 30, 2014 | 7.32% |
| Mar 31, 2014 | 16.12% |
| Dec 31, 2013 | 26.24% |
| Sep 30, 2013 | 33.71% |